About: Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 18 June 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu en xunu de 2020 (ast) scientific article published on 18 June 2020 (en) наукова стаття, опублікована 18 червня 2020 (uk)
publication date	wds:Q96576908-2B02B7DC-FA78-495A-9C77-F36E12DCB40A
publication date	2020-06-18 00:00:00Z (xsd:dateTime)
cites work	wds:Q96576908-85E65CBD-31F3-4861-8EA7-DAA6DAB1BE4D wds:Q96576908-8FFD37F9-7043-4BB3-A55F-08FD4C8EAB43 wds:Q96576908-BC80BCDF-032E-4BA0-AEB4-26C852426EE9
cites work	Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. COVID-19 in persons with chronic myeloid leukaemia
author name string	wds:Q96576908-00D97E93-0C8C-4EF4-B6FD-57E7B7A29162 wds:Q96576908-927EA21C-6FF7-41F1-806F-9F8B1862F8D2 wds:Q96576908-9E8067E7-B48A-4CB1-A608-DA25F5B52A18 wds:Q96576908-A2C40C50-EF8F-49B5-B8E3-8AE370EC570A
author name string	Gianantonio Rosti Alessandra Iurlo Gabriele Gugliotta Campus CML working group
rdfs:label	Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (en) Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (nl)
skos:prefLabel	Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (en) Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (nl)
name	Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (en) Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (nl)
author	wds:Q96576908-058BAFF1-9041-4433-9A42-9B887BCF0420 wds:Q96576908-08B1CA83-FF23-4504-A6A8-52C8956237B8 wds:Q96576908-0AF2B657-3C29-48D9-B764-E2D148022DE9 wds:Q96576908-11D59403-C116-4EF8-BDBA-CA36D792C3D7 wds:Q96576908-19AF3562-39A1-449C-8E5E-0679FC4D32E0 wds:Q96576908-220D8EAD-9ABB-4A65-9576-EF1BE64E393F wds:Q96576908-26229F24-9ED3-4F0D-9CD2-F3A47F30CD38 wds:Q96576908-2CB864C5-A13A-463F-90D7-BD5D82E24F8E wds:Q96576908-4199EBFE-34EC-4CAE-8B46-CDA8ED8532C1 wds:Q96576908-5C341996-5B3E-4CD3-B9D0-F2EE5C76070F wds:Q96576908-5CA0BB58-58AC-4887-A821-889446541FCA wds:Q96576908-809E34F6-4C9A-4A62-9B17-7D8ECB714E09 wds:Q96576908-93EDDDE9-7702-4111-94DC-BB4EE15E1825 wds:Q96576908-C0954C3B-8519-4A92-9C7E-FACE8E6CD1B3 wds:Q96576908-C924C058-DA4E-4C5E-80CF-98B5A173A88C wds:Q96576908-CC4B6D89-3A68-499D-B748-C0B5A4489C38
author	Elisabetta Abruzzese Roberto Latagliata Massimo Breccia Giuseppe Saglio Fabio Stagno Carmen Fava Fausto Castagnetti Monica Bocchia Mario Tiribelli Giovanna Rege Cambrin Antonella Gozzini Patrizia Pregno Luigiana Luciano Massimiliano Bonifacio Sara Galimberti Caterina Ilari
title	wds:Q96576908-F9BE0F17-9113-469D-953F-0CFBB3061550
title	Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey (en)
instance of	wds:Q96576908-6C240FEE-3E5F-4AFF-96B6-68F171E02EF5
instance of	scholarly article
main subject	wds:Q96576908-105B62DC-3040-4735-B731-088B20C86554 wds:Q96576908-57212395-E119-4D18-A503-0ACC3324EFCF wds:Q96576908-806D86E3-15C0-41C7-A31F-72178DAE38B4 wds:Q96576908-C5F84C3F-03DA-4497-A831-EE8DC60976A1
main subject	COVID-19 pandemic chronic myeloid leukemia Italy COVID-19 mortality
PubMed ID	wds:Q96576908-3A718054-5BD6-4419-A242-910FD8DC4148
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32555369
PubMed ID	32555369
published in	wds:Q96576908-569BF6B8-8552-480D-AEED-F4E40F4EE1EF
published in	Leukemia
DOI	wds:Q96576908-3461D898-596E-4AFC-B7A2-F1E695AF7E06
DOI	http://dx.doi.org/10.1038/S41375-020-0904-Z
DOI	10.1038/S41375-020-0904-Z
PMCID	wds:Q96576908-9006FBBB-2D30-49C4-B41C-CE25BA8E40BB
PMCID	7301058
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q96576908
is cites work of	COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs? Imatinib is not a potent anti-SARS-CoV-2 drug
is cites work of	wds:Q99547931-6FD1B566-0387-49F8-BBD8-D852A3B0219D wds:Q98726025-F6EEA249-5DFA-44A9-932A-3712574225F0 wds:Q90188788-DF204766-E4F2-459A-A671-BA7B7E6BFD48 wds:Q100395325-9608778D-C3A4-4B2D-936B-E1D22D985A4F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software